{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:19:39Z","timestamp":1774030779771,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Association DMLA"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Subretinal injections (SI) are used to deliver gene therapies for inherited retinal diseases, yet the optimal injection parameters remain undefined. This study used theoretical and experimental models to quantify the relationship between injection pressure, flow dynamics, and residual flow. A theoretical model (TM) was developed based on the Hagen-Poiseuille law and the theory of a jet immersed in the same liquid. An experimental model (EM) was constructed to allow for measuring flow and residual flow across injection pressures ranging from 0 to 20 psi. We assessed the effects of ambient pressure, injection system tubing length, and syringe priming technique. A minimum pressure of 6 psi was required to generate a detectable flow in the EM. Jet speed increased with the square root of injection pressure, aligning with theoretical predictions. Residual flow persisted for 28\u201347 seconds after injection and increased logarithmically with injection pressure. Elevated ambient pressure (45 mmHg) only reduced flow at lower injection pressures. The \u201clock-and-load\u201d priming method decreased jet speed and increased residual flow compared to the \u201cload-and-lock\u201d method. Both TM and EM quantified SI flow dynamics, with EM demonstrating residual flow at all tested pressures. To minimize complications, clinicians should use the lowest injection pressure and allow sufficient time for the cannula to be withdrawn from the subretinal space.<\/jats:p>","DOI":"10.1371\/journal.pone.0344836","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:29:19Z","timestamp":1774027759000},"page":"e0344836","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["A theoretical and experimental model of flow characteristics in subretinal injections"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9439-9256","authenticated-orcid":true,"given":"Reza","family":"Ladha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Merveille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Wyns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Scheid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Willermain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9217-5603","authenticated-orcid":true,"given":"Marc D.","family":"de Smet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"1","key":"pone.0344836.ref001","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000002609","article-title":"Surgical technique for subretinal gene therapy in humans with inherited retinal degeneration","volume":"39","author":"JL Davis","year":"2019","journal-title":"Retina"},{"issue":"16","key":"pone.0344836.ref002","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.3390\/jcm11164717","article-title":"Subretinal injection techniques for retinal disease: A review","volume":"11","author":"C Irigoyen","year":"2022","journal-title":"J Clin Med"},{"issue":"13","key":"pone.0344836.ref003","doi-asserted-by":"crossref","first-page":"10535","DOI":"10.3390\/ijms241310535","article-title":"The role of subretinal injection in ophthalmic surgery: Therapeutic agent delivery and other indications","volume":"24","author":"D Tripepi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"pone.0344836.ref004","doi-asserted-by":"crossref","first-page":"846782","DOI":"10.3389\/fmed.2022.846782","article-title":"Subretinal therapy: Technological solutions to surgical and immunological challenges","volume":"9","author":"R Ladha","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"pone.0344836.ref005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.oret.2023.08.017","article-title":"Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration","volume":"8","author":"N Bommakanti","year":"2024","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"pone.0344836.ref006","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000003576","article-title":"Retinal Pigment Epithelium Atrophy After Subretinal Voretigene Neparvovec-rzyl for RPE65-Related Disease: A 6-Month Follow-Up","volume":"42","author":"F Giansanti","year":"2022","journal-title":"Retina"},{"issue":"9","key":"pone.0344836.ref007","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bjophthalmol-2021-321023","article-title":"Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec","volume":"107","author":"FF Reichel","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"pone.0344836.ref008","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal Chorioretinal Atrophy after Subretinal Voretigene Neparvovec-rzyl for RPE65-Mediated Leber Congenital Amaurosis","volume":"6","author":"WS Gange","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"pone.0344836.ref009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.13.2.13","article-title":"Chorioretinal atrophy growth after voretigene neparvovec retinotopically is connected to retinal functional rescue","volume":"13","author":"K Stingl","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"pone.0344836.ref010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamaophthalmol.2022.6254","article-title":"Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations","volume":"141","author":"L von Krusenstiern","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"pone.0344836.ref011","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000522110","article-title":"Controlled subretinal injection pressure prevents damage in pigs","volume":"245","author":"ME Olufsen","year":"2022","journal-title":"Ophthalmologica"},{"key":"pone.0344836.ref012","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41434-021-00294-2","article-title":"Injection pressure levels for creating blebs during subretinal gene therapy","volume":"29","author":"BA Scruggs","year":"2022","journal-title":"Gene Ther"},{"key":"pone.0344836.ref013","first-page":"4485","article-title":"Defining parameters for robotic or manual reflux-free subretinal injections in an ex vivo animal model","volume":"61","author":"R Ladha","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pone.0344836.ref014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-1-4939-8669-9_26","article-title":"Optimized subretinal injection technique for gene therapy approaches","volume":"1834","author":"R M\u00fchlfriedel","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"9967","key":"pone.0344836.ref015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: Follow-up of two open-label phase 1\/2 studies","volume":"385","author":"SD Schwartz","year":"2015","journal-title":"Lancet"},{"key":"pone.0344836.ref016","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2147\/OPTH.S140218","article-title":"Epiretinal membrane in a subject after transvitreal delivery of palucorcel (CNTO 2476)","volume":"11","author":"R Spencer","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"pone.0344836.ref017","doi-asserted-by":"crossref","first-page":"100950","DOI":"10.1016\/j.preteyeres.2021.100950","article-title":"Immunological aspects of RPE cell transplantation","volume":"84","author":"S Sugita","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"pone.0344836.ref018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.10.1.10","article-title":"Hints for gentle submacular injection in non-human primates based on intraoperative OCT Guidance","volume":"10","author":"GSW Tan","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"12","key":"pone.0344836.ref019","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1167\/iovs.14-14493","article-title":"Ocular perfusion pressure during pars plana vitrectomy: A pilot study","volume":"55","author":"T Rossi","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pone.0344836.ref020","doi-asserted-by":"crossref","unstructured":"Bruus H. Theoretical Microfluidics. Oxford Academic; 1997.","DOI":"10.1093\/oso\/9780199235087.001.0001"},{"key":"pone.0344836.ref021","volume-title":"Fluid Mechanics: Volume 6","author":"LD Landau","year":"1987"},{"key":"pone.0344836.ref022","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/B978-012289676-7\/50010-2","article-title":"Principles of air and contaminant movement inside and around buildings","volume-title":"Industrial Ventilation Design Guidebook","author":"A Zhivov","year":"2001"},{"issue":"5","key":"pone.0344836.ref023","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.survophthal.2024.05.004","article-title":"Biomechanical considerations for optimising subretinal injections","volume":"69","author":"D L\u2019Abbate","year":"2024","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"pone.0344836.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209996","article-title":"The influence of subretinal injection pressure on the microstructure of the monkey retina","volume":"13","author":"K Takahashi","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"pone.0344836.ref025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/tvst.12.11.28","article-title":"A microfluidic platform for the time-resolved interrogation of polarized retinal pigment epithelial cells","volume":"12","author":"EC Spivey","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"pone.0344836.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178981","article-title":"Corneal epithelial cells exposed to shear stress show altered cytoskeleton and migratory behaviour","volume":"12","author":"S Molladavoodi","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0344836.ref027","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1039\/C5LC01006C","article-title":"Microfluidic assessment of mechanical cell damage by extensional stress","volume":"16","author":"YB Bae","year":"2016","journal-title":"Lab Chip"},{"issue":"4","key":"pone.0344836.ref028","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/hgtb.2016.086","article-title":"Evaluation of an optimized injection system for retinal gene therapy in human patients","volume":"27","author":"MD Fischer","year":"2016","journal-title":"Hum Gene Ther Methods"},{"issue":"1","key":"pone.0344836.ref029","article-title":"Semiautomated subretinal fluid injection method using viscous fluid injection mode","volume":"39","author":"HJ Kwon","year":"2019","journal-title":"Retina"},{"issue":"9","key":"pone.0344836.ref030","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/eye.2017.158","article-title":"Technique of retinal gene therapy: Delivery of viral vector into the subretinal space","volume":"31","author":"K Xue","year":"2017","journal-title":"Eye (Lond)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:29:26Z","timestamp":1774027766000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344836"}},"subtitle":[],"editor":[{"given":"Alan","family":"Marmorstein","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344836","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}